flutiform is the first pressurised metered-dose inhaler to combine the ICS, fluticasone propionate, with the fast-acting inhaled LABA, formoterol. 2 flutiform is licensed for asthma maintenance ...

DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...

The flutiform k-haler takes its name from a unique kinked valve which removes the need for co-ordination, with only gentle inhalation required to trigger the aerosol. Details of the four flutiform ...

Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma. Napp Pharmaceuticals says the UK is ...

- First presentation of largest ever real-world flutiform(R) study at European Respiratory Society International Congress involving over 2,500 patients - Proportion of patients with well-controlled ...

LONDON, UK, 1 December, 2014 - Skyepharma PLC (LSE SKP), the expert oral and inhalation drug development company, today announces that the 120-puff treatment version in strengths of 50/5µg and 125/5µg ...

LONDON, UK, 20 April, 2012 - SkyePharma PLC (LSE SKP) today announces that the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA") has issued a positive ...

k-haler is an award-winning[3] breath-triggered aerosol device utilising a patented "kinked" valve - the k-valve(TM) which has been designed with the aim to make it easier for patients to use ...

LONDON, UK, 1 September 2009 - SkyePharma PLC (LSE: SKP) today provides an update following a meeting held with the US Food and Drug Administration (FDA) to discuss the previously announced potential ...

LONDON, UK, 20 September, 2013 - Skyepharma PLC (LSE SKP), the expert oral and inhalation drug delivery company, announces that the Japanese Ministry of Health, Labour and Welfare ("MHLW"), has ...

- flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older)[1] - Research indicates that many patients make errors with their inhalers ...